Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2Thoracic 1NET 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1877Lung Neoplasms 1308Small Cell Lung Carcinoma 328Colorectal Neoplasms 269Breast Neoplasms 245Melanoma 222Neoplasms 218Ovarian Neoplasms 194Neoplasm Metastasis 182Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 151Stomach Neoplasms 144Head and Neck Neoplasms 120Carcinoma, Renal Cell 120Triple Negative Breast Neoplasms 111Esophageal Neoplasms 110Prostatic Neoplasms 106Endometrial Neoplasms 98Uterine Cervical Neoplasms 96Urinary Bladder Neoplasms 89Mesothelioma 88Colonic Neoplasms 86Mesothelioma, Malignant 81Carcinoma, Hepatocellular 74Brain Neoplasms 70Sarcoma 64Disease 62Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Liver Neoplasms 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Piebaldism × Thoracic × 1 year × Clear all
NCT06805825 2025-09-23

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Novelty Nobility, Inc.

Phase 1 Recruiting
67 enrolled
DermatologicEndocrineGastrointestinalGenitourinaryNETSarcomaThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Adenoid Cystic, Piebaldism, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡